Abstract:Sugai Liang, 1, &ast Yue Wu, 1, &ast Li Hanxiaoran, 1, &ast Andrew J Greenshaw, 2 Tao Li 1 1 Affiliated Mental Health Centre & Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310013, People's Republic of China; 2 Department of Psychiatry, University of Alberta, Edmonton, AB, T6G 2B7, Canada &astThese authors contributed equally to this work Correspondence: Tao Li, Affiliated Mental Health Centre & Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine, Hangzhou, 310013, Zhejiang, People's Republic of China, Tel +86 571 85126501, Fax +86 571 85121532, Email Anhedonia, which is defined as markedly diminished interest or pleasure, is a prominent symptom of psychiatric disorders, most notably major depressive disorder (MDD) and schizophrenia. Anhedonia is considered a transdiagnostic symptom that is associated with deficits in neural reward and aversion functions. Here, we review the characteristics of anhedonia in depression and schizophrenia as well as shared or disorder-specific anhedonia-related alterations in reward and aversion pathways of the brain. In particular, we highlight that anhedonia is characterized by impairments in anticipatory pleasure and integration of reward-related information in MDD, whereas anhedonia in schizophrenia is associated with neurocognitive deficits in representing the value of rewards. Dysregulation of the frontostriatal circuit and mesocortical and mesolimbic circuit systems may be the transdiagnostic neurobiological basis of reward and aversion impairments underlying anhedonia in these two disorders. Blunted aversion processing in depression and relatively strong aversion in schizophrenia are primarily attributed to the dysfunction of the habenula, insula, amygdala, and anterior cingulate cortex. Furthermore, patients with schizophrenia appear to exhibit greater abnormal activation and extended functional coupling than those with depression. From a transdiagnostic perspective, understanding the neural mechanisms underlying anhedonia in patients with psychiatric disorders may help in the development of more targeted and efficacious treatment and intervention strategies. Keywords: anhedonia, reward pathway, aversion circuit, depression, schizophrenia Anhedonia, which is characterized by a loss of interest or pleasure, reflects deficits in hedonic capacity and is closely related to the constructs of reward valuation, decision making, anticipation, and motivation. 1 Anhedonia is considered a transdiagnostic symptom that is associated with deficits in reward and aversion processing and is especially present in patients with major depressive disorder (MDD) and schizophrenia. 2–4 In addition, anhedonia is linked to greater severity of clinical symptoms, poorer treatment response, and poorer clinical outcomes in patients with these two disorders. 5–7 Anhedonia is a multidimensional construct that includes anticipatory anhedonia (inability to anticipate rewards), consummatory anhedonia (impairments in hedonic response to rewards), and motivational anhedonia (diminished motivation to pursue rewards). 8 The constructs of anhedonia have common and dissociable neural underpinnings. 9 Anhedonia is a core feature of MDD. 10 Patients with MDD have deficits in motivation for rewards owing to low anticipatory pleasure and reduced ability to modulate behavior in response to intermittent rewards. 11,12 In contrast, anhedonia in patients with schizophrenia is one of the cardinal negative symptoms and is independent of positive, disorganized, and depressive dimensions. 13 As defined in the "Schizophrenia Spectrum Anhedonia Paradox", hedonic capacity is impaired in individuals with schizotypy and youth at clinical high-risk, whereas it appears intact in patients with schizophrenia. Moreover, a higher frequency of anhedonia is detected during the chronic phase of schizophrenia than during the early phase of illness. 14 Anhedonia in schizophrenia may stem from deficits in integrating and maintaining representations of hedonic values, which results in impairments in anticipatory pleasure and goal-directed behavior. 15 Previous findings suggest that a common neural basis and genetic factors underlie anhedonia, which transcends the disorder categories of depression and schizophrenia. 16–18 Consistent with the Research Domain Criteria initiative focused on transdiagnostic dimensions of psychopathology, there is a crucial need for a more detailed approach to investigate specific properties at the symptom level. 19 A better understanding of the precise psychopathological and neuro -Abstract Truncated-

Effects of anhedonia on health-related quality of life and functional outcomes in major depressive disorder: A systematic review and meta-analysis

The Impacts of Anhedonia on Brain Functional Alterations in Patients with Major Depressive Disorder: A Resting-State Functional Magnetic Resonance Imaging Study of Regional Homogeneity.

Association of Anhedonia with Brain-Derived Neurotrophic Factor and Interleukin-10 in Major Depressive Disorder

Increased Ratio of Mature BDNF to Precursor-Bdnf in Patients with Major Depressive Disorder with Severe Anhedonia.

Aberrant Interhemispheric Functional Connectivity in Major Depressive Disorder with and Without Anhedonia.

Volume Changes of the Subcortical Limbic Structures in Major Depressive Disorder Patients with and Without Anhedonia.

Altered Hippocampal Subfield Volumes in Major Depressive Disorder with and Without Anhedonia.

Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review

Association of Cognitive Impairment with Anhedonia in Patients with Schizophrenia.

Increased Plasma Levels of IL-6 Are Associated with Striatal Structural Atrophy in Major Depressive Disorder Patients with Anhedonia

Evaluating Anhedonia as a risk factor in suicidality: A meta-analysis

Anhedonia in Depression and Schizophrenia: Brain Reward and Aversion Circuits

Define and characterize the anhedonia in major depressive disorder: An explorative study

Anhedonia in Major Depressive Disorder: Prevalence and Treatment Expectations and Satisfaction with Treatment Goals Among Patients and Physicians in Asia-Pacific

Anhedonia and dysregulation of an angular gyrus-centred and dynamic functional network in adolescent-onset depression

A comparative study of anhedonia components between major depression and schizophrenia in Chinese populations

Relationship Between Anhedonia and Psychosocial Functioning in Post-Covid-19 Condition: a Post-Hoc Analysis

High Efficiency of Left Superior Frontal Gyrus and the Symptom Features of Major Depressive Disorder.

The Efficacy of Vortioxetine on Anhedonia in Patients with Major Depressive Disorder

Relationship Between Anhedonia and Psychosocial Functioning in Post-Covid-19 Condition: a Post-Hoc Analysis Anhedonia and Psychosocial Functioning in Post-Covid-19 Condition

Exploring mechanisms of anhedonia in depression through neuroimaging and data-driven approaches